Buch, Englisch, 420 Seiten, Format (B × H): 191 mm x 235 mm
Strategies Against Sars-Cov-2 Variants in the Post-Pandemic Era
Buch, Englisch, 420 Seiten, Format (B × H): 191 mm x 235 mm
ISBN: 978-0-443-33002-5
Verlag: Elsevier Science
Nanotechnology and Antivirus Nanomaterials for Combating COVID-19: Strategies against SARS-CoV-2 Variants in the Post-pandemic Era explores the state-of-the-art and advancements in nanotechnology to fight SARS-CoV-2 and its variants. Providing a comprehensive overview, the chapters cover the molecular mechanisms of viral infection and advanced tools for diagnosis, prevention, treatments, drug development, and vaccine creation, offering valuable insights into managing COVID-19. The book also includes discussions on potential challenges and future research directions. This book is a valuable resource for researchers, scientists, and professionals seeking a deeper understanding of nanotechnology's applications for preventing, diagnosing, and managing COVID-19.
Autoren/Hrsg.
Fachgebiete
- Technische Wissenschaften Sonstige Technologien | Angewandte Technik Medizintechnik, Biomedizintechnik
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Medizintechnik, Biomedizintechnik, Medizinische Werkstoffe
- Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde
- Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie
Weitere Infos & Material
1. A comprehensive review of epidemiology, virology, and prevention for COVID-19 and its variants
2. Coronavirus Disease 2019 and the SARS-CoV-2 variants: Virological perspectives
3. Introduction to antiviral nanomaterials: Mechanisms and applications
4. An overview of antiviral nanomedicine: Types, structures and functions
5. Nanotechnology-based strategies for combating SARS-CoV-2 variants
6. Nanotechnology for diagnosis of COVID-19: Current achievements and future directions
7. Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent finding, limitations, and prospects
8. The development of lipid nanoparticle technology for the management of COVID-19
9. Nanotechnology for the prevention of SARS-CoV-2 infection
10. Nanotechnology-assisted therapeutic antibodies against SARS-CoV-2 variants: Current findings and future perspectives
11. COVID-19 drug delivery: Current achievements and the impact of nanocarriers
12. Nanotechnology-based drug delivery for combating SARS-CoV-2 variants
13. An overview of COVID-19 vaccine development: Highlighting the role of nanotechnology
14. Nanotechnology-based vaccine development for COVID-19
15. An updated overview of clinical trials, official approval, and risks for the application of nanomaterials in COVID-19 management
16. Anti-SARS-CoV-2 nanoparticles: Mechanisms and applications
17. Engineered nanoparticles for the management of COVID-19 and new variants of SARS-CoV-2
18. Nature’s arsenal: Combatting SARS-CoV-2 variants with phytocompound nanoparticles
19. Emerging nanomaterials for COVID-19 therapeutics
20. Metallic nanoparticles-based strategies for COVID-19 management in the post-pandemic era
21. Nanotechnological Approaches for COVID-19 Management: Highlighting the Impact on SARS-Co-V-2 Variants
22. Advancing Pandemic Response: The Impact of Nanodiagnostics on COVID-19 and Other Infectious Diseases
